Focus on safety as AstraZeneca pauses COVID-19 vaccine trial
Health officials and experts are emphasizing the need for potential COVID-19 vaccines to be safe after AstraZeneca and Oxford University paused their Phase 3 trial when a volunteer became seriously ill.